SMSbiotech
  • Contact us760-290-3400
  • Home
  • Company
    • About Us
    • Leadership
  • Science
    • Science
    • Insight
      • Aging
      • Blood Vessel Formation and Cancer
      • Blood Vessel Regression
      • Cancer
      • Cell Based Microfluidics
      • Cellular Spheroids, Aggregates, Assembly
      • Diabetic Ulcers
      • ECM and Aging
      • ECM and Cancer
      • ECM and Tissue Repair
      • Exosomes
      • Organoids
      • Stem Cells
    • Upcoming Presentations
    • Past Presentations
  • Products
    • Products
    • Resources
      • Application Notes
      • Product Instructions
      • MSDS Sheets
      • White Papers
  • Pipeline
  • News
  • COVID-19 Treatment Proposal
  • Contact Us
Press enter to begin your search
Category

Upcoming Presentations

  • Article Topics

    • Company News 25
      • Interview 7
      • Past Presentations 12
    • Coronavirus 21
    • Products 2
      • ANGIOstream – VG 4
      • INM – Inductive Niche Module 1
    • Science 9
      • Insight 33
        • Aging 4
        • Blood Vessel Formation and Cancer 2
        • Blood Vessel Regression 1
        • Cancer 3
        • Cell Based Microfluidics 1
        • Cellular Spheroids, Aggregates, Assembly 3
        • COVID-19 4
        • Diabetic Ulcers 2
        • ECM and Aging 4
        • ECM and Cancer 2
        • ECM and Tissue Repair 1
        • Exosomes 3
        • MSC 2
        • Organoids 2
        • Stem Cells 6

Recent Posts

  • Prof. Peter D. Wagner, MD joins SMSbiotech on their Advisory Board
  • SMSbiotech Completes Second Clinical Test for Chronic Non-Healing Wound Product
  • In Vitro Gene Expression Study Demonstrates Small Mobile Stem Cells Stimulate Progenitor Lung Cells
  • SMSbiotech Completes Clinical Test for Chronic Non-Healing Wound Product
  • Stem Cell Therapy Shows 2-year Benefit for Progressive MS Patients in Phase 1 Trial

Archives

  • April 2021
  • March 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • October 2019
  • August 2019
  • June 2019
  • September 2018
  • August 2018
  • March 2018
  • February 2018
  • October 2016
  • June 2016
  • March 2015
  • October 2013

SMSbiotech

SMSbiotech, Inc. is a California-based biotech company. Our goal is to revolutionize how the life sciences industry explores, examines, assesses and manipulates cells, drugs and toxins. Our stem cell technology will lead to the development of more efficient and relevant medicines.

Information

  • Careers
  • Investors
  • Pipeline

quick links

Home Contact Us Terms of Sale Terms & Conditions

Contact Details

1825 DIAMOND ST STE 101
SAN MARCOS, CA 92078

UNITED STATES

CALL US: 760-290-3406

EMAIL US: INFO@SMSBIOTECH.COM TECHNICALSUPPORT@SMSBIOTECH.COM

© 2019 - SMSbiotech. All Right Reserved.

  • Home
  • Company
    • About Us
    • Leadership
  • Science
    • Science
    • Insight
      • Aging
      • Blood Vessel Formation and Cancer
      • Blood Vessel Regression
      • Cancer
      • Cell Based Microfluidics
      • Cellular Spheroids, Aggregates, Assembly
      • Diabetic Ulcers
      • ECM and Aging
      • ECM and Cancer
      • ECM and Tissue Repair
      • Exosomes
      • Organoids
      • Stem Cells
    • Upcoming Presentations
    • Past Presentations
  • Products
    • Products
    • Resources
      • Application Notes
      • Product Instructions
      • MSDS Sheets
      • White Papers
  • Pipeline
  • News
  • COVID-19 Treatment Proposal
  • Contact Us
error: Content is Property of SMSbiotech